Search Results
α-Cyano-4-hydroxycinnamic acid 50mg | ≥98%
CSNpharm
α-Cyano-4-hydroxycinnamic acid is a MCT inhibitor with antitumoral and antiangiogenic activity.
More Information Supplier Pageα-Cyano-4-hydroxycinnamic acid 250mg | ≥98%
CSNpharm
α-Cyano-4-hydroxycinnamic acid is a MCT inhibitor with antitumoral and antiangiogenic activity.
More Information Supplier PageCNQX 10mg | ≥98%
CSNpharm
CNQX 100mg | ≥98%
CSNpharm
CNQX 25mg | ≥98%
CSNpharm
BMS-309403 5mg | ≥99%
CSNpharm
BMS-309403 is an inhibitor of fatty acid binding protein 4 (FABP4) with Ki of less than 2 nM that decreases fatty acid uptake in adipocytes in vitro.
More Information Supplier PageBMS-309403 10mg | ≥99%
CSNpharm
BMS-309403 is an inhibitor of fatty acid binding protein 4 (FABP4) with Ki of less than 2 nM that decreases fatty acid uptake in adipocytes in vitro.
More Information Supplier PageBMS-309403 25mg | ≥99%
CSNpharm
BMS-309403 is an inhibitor of fatty acid binding protein 4 (FABP4) with Ki of less than 2 nM that decreases fatty acid uptake in adipocytes in vitro.
More Information Supplier Page(+)-PD 128907 HCl 50mg | ≥99%
CSNpharm
(+)-PD 128,907 HCl is an agonist of D3 dopamine receptor with Ki of 2.3 nM.
More Information Supplier Page
